Real-Time Imaging of Bacterial Infection in a Mouse Model Using Bioluminescence
JoVE Encyclopedia of Experiments
Microbiology
0 views • 2:12 min • January 30th, 2026
Take an anesthetized mouse pre-infected with a pathogenic bacterial strain engineered to express a genetically integrated bioluminescence operon.
The operon encodes luciferase and a multienzyme complex that synthesizes its substrate.
The luciferase enzyme catalyzes a reaction with these substrates, producing visible luminescence.
Place the mouse in a supine position on the temperature-stabilized platform of an imaging chamber and maintain anesthesia during imaging.
Use the imaging system to capture both bioluminescent and corresponding X-ray images of the mouse.
The bioluminescent image reveals the extent of bacterial infection, while the X-ray image provides an anatomical reference for infection localization.
After imaging, return the mouse to its cage and allow recovery.
Capture bioluminescence images at regular intervals to monitor the real-time progression of the bacterial infection.
Over time, the presence of bioluminescent signals at various locations confirms the spread of the infection throughout the host.
To image the animals, prepare the imaging system by setting the camera parameters and heating the stage. Set the oxygen flow to 1.5 liters per minute and isoflurane to 3.5% and move the mouse to the anesthetic chamber, then to the temperature stabilized stage, following anesthesia. Position the mouse on its back with arms outstretched and fit a nose cone for administration of 2.5% isoflurane during imaging.
Close the door and take bioluminescent images and X-rays of the mouse. When imaging is complete, return the mouse to its cage and monitor it. It should regain consciousness within 3 to 5 minutes.
Overview
This article describes a method for imaging bacterial infections in anesthetized mice using bioluminescence and X-ray imaging. The technique allows for real-time monitoring of infection progression and localization within the host.
Key Study Components
Area of Science
- Microbiology
- Imaging Techniques
- Infectious Disease Research
Background
- Understanding bacterial infections is crucial for developing effective treatments.
- Bioluminescence imaging provides a non-invasive way to visualize infections.
- X-ray imaging offers anatomical context for the infection's location.
- This study utilizes a genetically modified bacterial strain for enhanced imaging.
Purpose of Study
- To develop a method for real-time monitoring of bacterial infections in vivo.
- To correlate bioluminescent signals with anatomical structures via X-ray imaging.
- To assess the spread of infection over time in a living organism.
Methods Used
- Anesthetized mice infected with a bioluminescent bacterial strain were used.
- Mice were positioned in a temperature-stabilized imaging chamber.
- Bioluminescent and X-ray images were captured simultaneously.
- Regular imaging intervals were established to monitor infection progression.
Main Results
- Bioluminescent imaging revealed the extent and spread of bacterial infection.
- X-ray imaging provided anatomical references for infection localization.
- Real-time monitoring showed changes in bioluminescent signals over time.
- The method demonstrated effectiveness in tracking infection dynamics.
Conclusions
- The combination of bioluminescence and X-ray imaging is effective for studying bacterial infections.
- This approach allows for non-invasive monitoring of infection progression.
- The findings can aid in the development of new therapeutic strategies.
Frequently Asked Questions
Executive Industry Relevance
Real-time imaging of bacterial infection in live animal models enables early assessment of virulence attenuation and therapeutic efficacy. This bioluminescence-X-ray correlative approach supports mechanistic de-risking in antimicrobial target validation by providing quantitative, spatially resolved infection dynamics. The method enhances predictive confidence in lead identification by reducing ambiguity in pathogen-host interaction studies.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses through direct visualization of infection spread and attenuation.
- Operational Value: Supports functional target validation by correlating genetic modifications with measurable changes in bioluminescent signal over time.
- Predictive Value: Facilitates portfolio triage by providing early, in vivo evidence of virulence reduction in candidate mutants.
Screening & Assay Development
- Scientific Value: Generates quantitative, longitudinal readouts of bacterial burden suitable for high-content screening workflows.
- Operational Value: Establishes a standardized, reproducible platform for comparing virulence across strain libraries.
- Scalability: Compatible with longitudinal study designs requiring repeated non-invasive imaging sessions.
Translational & Preclinical Research
- Scientific Value: Maintains disease relevance by monitoring infection in a physiologically intact host environment.
- Operational Value: Provides anatomical localization via X-ray co-registration, improving precision in pathology correlation.
- Predictive Confidence: Enables risk-adjusted advancement decisions by tracking infection kinetics and dissemination patterns.
Pipeline & Workflow Integration
The method integrates into the discovery continuum from target validation through lead optimization, supporting go/no-go decisions based on in vivo infection dynamics.
- Discovery Biology: Supports hypothesis testing by linking genetic perturbations to measurable changes in infection progression.
- Screening: Delivers assay-ready, quantitative bioluminescent outputs that enable comparison of virulence phenotypes.
- Analytics: Generates temporal and spatial infection metrics that facilitate cross-condition comparison and statistical evaluation.
- Translational Research: Connects early discovery to preclinical validation through continuous monitoring of infection in living systems.
- Enterprise Reuse: Functions as a reusable imaging platform applicable across multiple antimicrobial programs and target classes.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity in host-pathogen interactions through direct, real-time visualization.
- Operational Value: Ensures standardization and reproducibility via controlled anesthesia, imaging parameters, and longitudinal sampling.
- Strategic Value: Improves go/no-go decision quality by providing early, in vivo efficacy signals, reducing late-stage failure risk.
- Portfolio Impact: Enables risk-adjusted prioritization of antimicrobial candidates based on validated attenuation profiles.
Implementation Considerations
- Requires expertise in animal handling, anesthesia maintenance, and biosafety protocols for pathogenic strains.
- Dependent on access to bioluminescence-capable imaging systems with X-ray co-registration functionality.
- Necessitates standardization of imaging intervals, animal positioning, and signal quantification across study groups.
- Involves adaptation considerations when extending to different bacterial species or infection models.
- Limited by the need for genetic engineering of pathogens to express lux operons, which may not be feasible for all strains.
Biopharma FAQs
Live-Cell Fluorescence Microscopy to Investigate Subcellular Protein Localization and Cell Morphology Changes in Bacteria
Related Videos
0 Views
Visualization of Gut Microbiota-host Interactions via Fluorescence In Situ Hybridization, Lectin Staining, and Imaging
Related Videos
0 Views
High-Resolution Three-Dimensional Whole-Organ Tomography of Microbial Infections
Related Videos
0 Views
Using Luciferase to Image Bacterial Infections in Mice
Related Videos
0 Views
Bioluminescent Bacterial Imaging In Vivo
Related Videos
0 Views
Tracking Bacterial Infection Dynamics in a Mouse Using Bioluminescence
Related Videos
0 Views
Bioluminescence Imaging of Bacterial Infections in Mice
Related Videos
0 Views
Visualization of Urinary Tract Infection in a Mouse Model Using Bioluminescence
Related Videos
0 Views
Bioluminescence Imaging of Acinetobacter baumannii-Infected Burn Wounds in Mice
Related Videos
0 Views
Bioluminescence Imaging to Track Bacterial Infection and Wound Healing in a Mouse Model
Related Videos
0 Views
Last updated: 29 August 2026